Masimo Gains FDA Clearance for Continuous Oxygen Delivery Monitoring
IRVINE, Calif., August 25, 2026 Masimo, a Danaher company focused on specialty diagnostics and patient monitoring technologies, announced that...
hemodynamic monitoring
Advertisement
VetrixBio’s VTX-304 Shows Promise for Canine Osteoarthritis
RALEIGH, North Carolina, June 5, 2026 VetrixBio has announced encouraging first clinical data for VTX-304, its investigational first-in-class bispecific...
Neuronoff Implants First Patient in Injectrode Bladder Trial
CLEVELAND, Ohio and HOUSTON, Texas, June 5, 2026 Neuronoff has achieved a major clinical milestone with the successful implantation...
Retia and Medtronic Expand Access to Argos Cardiac Monitoring Technology in Western Europe
WHITE PLAINS, New York, June 5, 2026 Retia Medical has announced a significant expansion of its commercial partnership with...
FDA Clears Argos Infinity for Advanced Cardiac Monitoring
WHITE PLAINS, NEW YORK, UNITED STATES — February 16, 2026 Retia Medical has received U.S. FDA 510(k) clearance for...
Advertisement
